Research
Periodic Report
Biocon Hits 52-Week High on USFDA Nod, Dixon Rallies on Tech Acquisition, ICICI Prudential Slips on Weak Q1 Metrics
Biocon Hits 52-Week High on USFDA Nod, Dixon Rallies on Tech Acquisition, ICICI Prudential Slips on Weak Q1 Metrics
Written by - Fisdom Research
Array
July 16, 2025
2 minutes
Array
Market Snapshot
Benchmark indices Nifty and Sensex ended flat on July 16 after a rangebound trading session.
Nifty recovered from an intraday low of 25,121 to close above the 25,200 mark, supported by select buying.
Gains in auto, financials, IT, and realty stocks helped offset early losses.
Sector-wise, the metal index declined 0.6%, while the pharma index was down 0.3%.
On the positive side, realty, auto, FMCG, IT, PSU Bank, and media indices gained between 0.5% to 1.8%.
Sectoral Trends
Sector Name
% Change
Sector Name
% Change
NIFTY PSU BANK
1.8
NIFTY FMCG
0.5
NIFTY MEDIA
1.3
NIFTY AUTO
0.4
NIFTY IT
0.6
NIFTY OIL & GAS
0.2
NIFTY REALTY
0.5
NIFTY CONSUMER DURABLES
0.1
Top News
Biocon Ltd shares hit a fresh 52-week high on July 16 after its subsidiary received USFDA approval for Kristy, a rapid-acting insulin analog for diabetes treatment.
Dixon Technologies rose over 3% after signing a binding term sheet to acquire a 51% stake in Kunshan Q Tech India, gaining access to advanced camera and fingerprint module technology.
ICICI Prudential fell 3% as investors reacted to weaker June quarter results, marked by a decline in APE growth, short-term persistency ratios, and investment income.
Top Gainers and Losers
Top Gainers
% Change
Top Losers
% Change
M&M
2.4
SHRIRAMFIN
-2.4
WIPRO
2.2
ETERNAL
-1.6
TECHM
1.9
SUNPHARMA
-1.4
Trade Ideas Update
Our trade ideas success rate has 88% over the past month, even with increased volatility in the benchmark index. Follow Trade Ideas for timely stock insights.
